XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:    
Net loss $ (19,025) $ (9,499)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 63 1,125
Warrant revaluation expense (income) 9,723 (7,511)
Derivative revaluation income (541) 0
Inventory reserve 0 151
Depreciation and amortization 184 391
Loss on disposal or impairment of property and equipment 40 3,970
Recovery of doubtful accounts 0 (12)
Decrease (increase) in operating assets:    
Accounts receivable 0 12
Inventory 0 222
Prepaid expenses and other current assets 72 728
Other assets (19) (64)
Increase (decrease) in operating liabilities:    
Accounts payable 192 (3)
Related party payable 736 (9,796)
Accrued expenses and deferred rent (776) (518)
Accrued interest payable 368 0
Deferred revenue 0 (49)
Net cash used in operating activities (8,983) (20,853)
Cash flows from investing activities:    
Purchase of property and equipment (243) (143)
Net cash used in investing activities (243) (143)
Cash flows from financing activities:    
Proceeds from 2017 Series A Preferred Stock Offering, (net of offering costs of $377) 7,623 0
Payment of deferred offering costs 0 (109)
Principal payments on capital lease obligations 0 (2)
Net cash provided by (used in) financing activities 7,623 (111)
Net decrease in cash and cash equivalents (1,603) (21,107)
Cash and cash equivalents, beginning of period 17,515 29,268
Cash and cash equivalents, end of period 15,912 8,161
Supplemental disclosures of cash flow information:    
Property and equipment in accounts payable 26 46
Offering costs in accounts payable and accrued expenses 0 11
Reduction of warrant liability upon cashless exercise of warrants 41 0
Reduction in accrued interest payable upon cashless exercise of promissory notes 2 0
Dividend paid in-kind to preferred stockholders 100 0
Deemed dividend on preferred stock $ 3,870 $ 0